MediPharm Labs (TSX:LABS) Total Inventories : C$9.19 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Total Inventories?

MediPharm Labs's total inventories for the quarter that ended in Sep. 2024 was C$9.19 Mil. MediPharm Labs's average total inventories from the quarter that ended in Jun. 2024 to the quarter that ended in Sep. 2024 was C$9.38 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. MediPharm Labs's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was C$0.03.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. MediPharm Labs's Days Inventory for the three months ended in Sep. 2024 was 128.23.

Inventory Turnover measures how fast the company turns over its inventory within a year. MediPharm Labs's Inventory Turnover for the quarter that ended in Sep. 2024 was 0.71.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. MediPharm Labs's Inventory-to-Revenue for the quarter that ended in Sep. 2024 was 0.96.

MediPharm Labs Total Inventories Historical Data

The historical data trend for MediPharm Labs's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Total Inventories Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Inventories

Get a 7-Day Free Trial

51.49

22.14

10.98

7.78

9.90

MediPharm Labs Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Inventories	Get a 7-Day Free Trial															10.40	9.90	9.85	9.58	9.19

MediPharm Labs Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

MediPharm Labs (TSX:LABS) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

MediPharm Labs's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is

	Net-Net Working Capital Per Share (Q: Sep. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(13.092	+	0.75 * 6.228	+	0.5 * 9.193	-	10.795
-	0	-	0)	/	411.07
=	0.03

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

MediPharm Labs's Days Inventory for the three months ended in Sep. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2024 )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
	=	9.384	/	6.678	*	365 / 4
	=	128.23

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

MediPharm Labs's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2024 )	/	Average Total Inventories (Q: Sep. 2024 )
	=	6.678	/	9.384
	=	0.71

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

MediPharm Labs's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	9.384	/	9.798
	=	0.96

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

MediPharm Labs Total Inventories Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan	Director
Gregory Edison Hunter	Senior Officer
David Pidduck	Director, Senior Officer
Bryan Howcroft	Director, Senior Officer
Patrick Mccutcheon	Director
Warren Everitt	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust	10% Security Holder
Christopher David Taves	Director
Sybil Taylor	Senior Officer
Braden Fenske	Senior Officer
David John Mayers	Senior Officer